Cargando…
Potential of Osteopontin in the Management of Epithelial Ovarian Cancer
BACKGROUND: Osteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value o...
Autores principales: | Cerne, Katarina, Hadzialjevic, Benjamin, Skof, Erik, Verdenik, Ivan, Kobal, Borut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411016/ https://www.ncbi.nlm.nih.gov/pubmed/30712025 http://dx.doi.org/10.2478/raon-2019-0003 |
Ejemplares similares
-
Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites
por: Jakimovska, Marina, et al.
Publicado: (2014) -
High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrence
por: Jakimovska, Marina, et al.
Publicado: (2020) -
Soluble osteopontin concentrations in serum and ascites of women with advanced serous ovarian cancer
por: Černe, Katarina, et al.
Publicado: (2012) -
Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy
por: Jerman, Katarina Galic, et al.
Publicado: (2014) -
The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
por: Škof, Erik, et al.
Publicado: (2016)